# Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

> **NCT02627924** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 91 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02627924
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-18
- **Primary completion:** 2017-12-28
- **Final completion:** 2017-12-28
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627924, "Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02627924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*